Tag: ATTRCM

Alnylam Prescription drugs’ SWOT evaluation: inventory poised for progress as ATTR-CM drug reveals promise By Investing.com

Alnylam Prescription drugs (NASDAQ:ALNY), a pacesetter in RNA interference (RNAi) therapeutics, has…

By Tycoon Herald 16 Min Read